Hematopoietic stem cell transplantation (HSCT) is an accepted treatment for a variety of hematologic malignancies. The profound immunosuppression these patients experience adversely affects their risk of infection. This risk is much higher than in the general population and requires aggressive diagnostic and therapeutic interventions. The chapter will outline the major infections after HSCT.
CITATION STYLE
Ramaprasad, C., & Pursell, K. J. (2014). Infectious complications of stem cell transplantation. Cancer Treatment and Research, 161, 351–370. https://doi.org/10.1007/978-3-319-04220-6_12
Mendeley helps you to discover research relevant for your work.